Search Results - "Hou, Jianhao"

  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Targeting MK2 Is a Novel Approach to Interfere in Multiple Myeloma by Guo, Mengjie, Sun, Dongdong, Fan, Zhimin, Yuan, Yuxia, Shao, Miaomiao, Hou, Jianhao, Zhu, Yuqi, Wei, Rongfang, Zhu, Yan, Qian, Jinjun, Li, Fei, Yang, Ye, Gu, Chunyan

    Published in Frontiers in oncology (08-08-2019)
    “…MAPKAPK2 (MK2), the direct substrate of p38 MAPK, has been well-acknowledged as an attractive drug target for cancer therapy. However, few studies have…”
    Get full text
    Journal Article
  2. 2

    The impact of the bone marrow microenvironment on multiple myeloma (Review) by Hou, Jianhao, Wei, Rongfang, Qian, Jinjun, Wang, Ronggen, Fan, Zhimin, Gu, Chunyan, Yang, Ye

    Published in Oncology reports (01-10-2019)
    “…Multiple myeloma (MM) is characterized by the accumulation of monoclonal plasma cells in the bone marrow (BM). The interaction between the BM microenvironment…”
    Get full text
    Journal Article
  3. 3

    Multi-source seismic geological ahead-prospecting for TBM tunneling in fractured strata: improved strategies and case studies in a water conveyance project, China by Liu, Zhengyu, Bai, Peng, Chen, Lei, Gao, Chao, Li, Chao, Hou, Jianhao, Wei, Yishan, Xu, Xiaolin

    “…The Tunnel Boring Machine has inherent limitations in adapting to adverse geological conditions. When operating in complex strata, encounters with challenging…”
    Get full text
    Journal Article
  4. 4

    BTK induces CAM-DR through regulation of CXCR4 degradation in multiple myeloma by Wang, Wang, Wei, Rongfang, Liu, Shijia, Qiao, Li, Hou, Jianhao, Gu, Chunyan, Yang, Ye

    Published in American journal of translational research (01-01-2019)
    “…Cellular adhesion-mediated drug resistance (CAM-DR) occurs frequently in patients with relapsed or refractory multiple myeloma (MM). Elucidating the mechanism…”
    Get full text
    Journal Article
  5. 5

    Bioactive Compounds from Abelmoschus manihot L . Alleviate the Progression of Multiple Myeloma in Mouse Model and Improve Bone Marrow Microenvironment by Hou, Jianhao, Qian, Jinjun, Li, Zhenlin, Gong, Aixiu, Zhong, Sixia, Qiao, Li, Qian, Shihui, Zhang, Yanxin, Dou, Renjie, Li, Rui, Yang, Ye, Gu, Chunyan

    Published in OncoTargets and therapy (01-01-2020)
    “…(L.) Medik. (Malvaceae) derived Huangkui capsules (HKC) represent a traditional Chinese medicine that has been widely applied to the clinical therapy of kidney…”
    Get full text
    Journal Article
  6. 6

    Loquat leaf polysaccharides improve glomerular injury in rats with anti-Thy 1 nephritis via peroxisome proliferator-activated receptor alpha pathway by Lu, Ting, Fan, Zhimin, Hou, Jianhao, Qi, Xiaohong, Guo, Mengjie, Ju, Jianming, Yang, Ye, Gu, Chunyan

    Published in American journal of translational research (01-01-2019)
    “…Chronic glomerulonephritis frequently develops into renal failure that cannot be completely cured. Based on the success of anti-inflammatory Chinese herbs in…”
    Get full text
    Journal Article
  7. 7

    In vitro and in vivo efficacy of the novel oral proteasome inhibitor NNU546 in multiple myeloma by Zhou, Hui, Lei, Meng, Wang, Wang, Guo, Mengjie, Wang, Jia, Zhang, Haoyang, Qiao, Li, Feng, Huayun, Liu, Zhaogang, Chen, Lijuan, Hou, Jianhao, Wang, Xueyuan, Gu, Chenxi, Zhao, Bo, Izumchenko, Evgeny, Yang, Ye, Zhu, Yongqiang

    Published in Aging (Albany, NY.) (16-11-2020)
    “…Proteasome inhibition demonstrates highly effective impact on multiple myeloma (MM) treatment. Here, we aimed to examine anti-tumor efficiency and underlying…”
    Get full text
    Journal Article